Non-Detection of HCMV Total Genomic DNA in Human Glioma Cells Genome

被引:1
作者
Gokturk, Dilek [1 ]
Alkis, M. Damla Ozdemir [1 ]
Yilmaz, Dervis Mansuri [2 ]
机构
[1] Adana Alparslan Turkes Sci & Technol Univ, Fac Engn, Dept Bioengn, Adana, Turkiye
[2] Cukurova Univ, Fac Med, Dept Neurosurg, Adana, Turkiye
关键词
Glioma; Surgical treatment; HCMV; qPCR; HUMAN CYTOMEGALOVIRUS-INFECTION; GLIOBLASTOMA; VALGANCICLOVIR; EXPRESSION;
D O I
10.5137/1019-5149.JTN.42717-22.1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AIM: To demonstrate if the human cytomegalovirus (HCMV) genome, that is involved in the pathogenesis of gliomas, is part of the genomic DNA of glioma cells or not. MATERIAL and METHODS: The study included U87MG glioblastoma cell culture and tumor samples from glioma patients. The genomic DNA of tumor samples and U87MG cells were extracted and real-time quantitative PCR was used to assess the presence of the human cytomegalovirus genomic DNA. RESULTS: Consequently, HCMV positivity was not detected in the tumor and cell line genomic DNA under the aforementioned experimental conditions. CONCLUSION: We found that the genomic DNA of all the samples was negative for HCMV genomic DNA. Thus, HCMV could not be detected in human glioma tumors and we put forward that HCMV genomic DNA was not incorporated into the genomic DNA of glioma cells. Thus, total viral DNA is not involved in the pathogenesis of glioma; however, small viral particles or specific genes might be incorporated into the genomic DNA of glioma cells, leading to cancer development. This prompts further studies for verification.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 29 条
[1]   Cytomegalovirus: pathogen, paradigm, and puzzle [J].
Boeckh, Michael ;
Geballe, Adam P. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (05) :1673-1680
[2]   Does valganciclovir have a role in glioblastoma therapy? [J].
Cobbs, Charles S. .
NEURO-ONCOLOGY, 2014, 16 (03) :330-331
[3]  
Cobbs CS, 2002, CANCER RES, V62, P3347
[4]  
DURMAZ R., 2007, Turk Norosirurji Dergisi, V17, P80
[5]   Consensus on the role of human cytomegalovirus in glioblastoma [J].
Dziurzynski, Kristine ;
Chang, Susan M. ;
Heimberger, Amy B. ;
Kalejta, Robert F. ;
Dallas, Stuart R. McGregor ;
Smit, Martine ;
Soroceanu, Liliana ;
Cobbs, Charles S. .
NEURO-ONCOLOGY, 2012, 14 (03) :246-255
[6]   Design and synthesis of a potent macrocyclic 1,6-napthyridine anti-human cytomegalovirus (HCMV) inhibitors [J].
Falardeau, G ;
Lachance, H ;
St-Pierre, A ;
Yannopoulos, CG ;
Drouin, M ;
Bédard, J ;
Chan, L .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1693-1695
[7]   Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form [J].
Khaiboullina, SF ;
Maciejewski, JP ;
Crapnell, K ;
Spallone, PA ;
Dean Stock, A ;
Pari, GS ;
Zanjani, ED ;
St Jeor, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) :410-417
[8]  
Lepiller Quentin, 2011, Open Virol J, V5, P60, DOI 10.2174/1874357901105010060
[9]   The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [J].
Louis, David N. ;
Perry, Arie ;
Reifenberger, Guido ;
von Deimling, Andreas ;
Figarella-Branger, Dominique ;
Cavenee, Webster K. ;
Ohgaki, Hiroko ;
Wiestler, Otmar D. ;
Kleihues, Paul ;
Ellison, David W. .
ACTA NEUROPATHOLOGICA, 2016, 131 (06) :803-820
[10]   The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions [J].
Michaelis, Martin ;
Doerr, Hans W. ;
Cinatl, Jindrich, Jr. .
NEOPLASIA, 2009, 11 (01) :1-9